Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $126.19 USD
Change Today -0.26 / -0.21%
Volume 512.2K
BMRN On Other Exchanges
As of 3:20 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Henry J. Fuchs M.D., Ph.D.

Chief Medical Officer and Executive Vice President,BioMarin Pharmaceutical Inc.
AgeTotal Calculated CompensationThis person is connected to 58 board members in 5 different organizations across 8 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Henry J. Fuchs, also known as Hank, M.D., Ph.D. has been the Chief Medical Officer of BioMarin Pharmaceutical Inc. since March 2, 2009 and serves as its Executive Vice President. Dr. Fuchs served as Senior Vice President of BioMarin Pharmaceutical Inc., from March 2, 2009 to December 2009. He served as the President of Intrabiotics Pharmaceuticals Inc. from November 2001 to June 2005 and served as its Chief Executive Officer from January 27, 2003 to June 2005. He ...

Read Full Background

Corporate Headquarters*

770 Lindaro Street
San Rafael, California 94901

United States

Phone: 415-506-6700
Fax: 415-382-7889

Board Members Memberships*

Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
Independent Director, Chairman of Science & Technology Advisory Committee, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee


Harvard University
George Washington University
PhD 1975
The University of Utah

Other Affiliations*

Annual Compensation*

Total Annual Compensation$528,235

Stock Options*

Restricted Stock Awards$984,360
All Other Compensation$18,338
Exercised Options40,000
Exercised Options Value$2,197,548
Exercisable Options199,320
Exercisable Options Value$10,767,014
Unexercisable Options136,080
Unexercisable Options Value$4,321,216
Total Value of Options$17,285,778
Total Number of Options375,400

Total Compensation*

Total Annual Cash Compensation$796,686
Total Short Term Compensation$528,235
Other Long Term Compensation$1,002,698
Total Calculated Compensation$3,575,094
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BMRN:US $126.44 USD -0.01


Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
Herve Hoppenot Chief Executive Officer, President, Director and Member of Non-Management Stock Option Committee
Incyte Corporation
Craig A. Wheeler Chief Executive Officer, President and Executive Director
Momenta Pharmaceuticals Inc.
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOMARIN PHARMACEUTICAL INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at